ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Waldmann, Fisher Win Top Miken Prizes Of $250,000 Each, Six Others Get $50,000

November 10, 1989

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

Edward Benz Named President Of Dana-Farber Cancer Institute.

July 28, 2000

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

HHS Reports Some Gains In Reducing Health Disparities

February 8, 2002

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002